Ischemia-reperfusion injury: Influencing the microcirculatory and cellular environment

Annals of Plastic Surgery

Volumn 72, Issue 2, 2014, Pages 253-260

  Widgerow, Alan D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

apoptosis; conditioning; ischemia; mitochondrial permeability; reperfusion; ROS

Indexed keywords

CARDIOVASCULAR AGENT; CELL ADHESION MOLECULE; ENDOTHELIUM DERIVED RELAXING FACTOR; HYDROGEN SULFIDE; NITRIC OXIDE; SCAVENGER;

DRUG ANTAGONISM; HUMAN; INDUCED HYPOTHERMIA; ISCHEMIA; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; MICROCIRCULATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REPERFUSION INJURY; REVIEW;

CARDIOVASCULAR AGENTS; CELL ADHESION MOLECULES; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; FREE RADICAL SCAVENGERS; HUMANS; HYDROGEN SULFIDE; HYPOTHERMIA, INDUCED; ISCHEMIA; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; MICROCIRCULATION; NITRIC OXIDE; REPERFUSION INJURY;

EID: 84892948326     PISSN: 01487043     EISSN: 15363708     Source Type: Journal    
DOI: 10.1097/SAP.0b013e31825c089c     Document Type: Article

References (64)

1. Eisenhardt SU, Schmidt Y, Karaxha G, et al. Monitoring molecular changes induced by ischemia/reperfusion in human free muscle flap tissue samples. Ann Plast Surg. 2012;68:202-208
2. Khalil AA, Aziz FA, Hall JC. Reperfusion injury. Plast Reconstr Surg. 2006;117:1024-1033
3. Levitsky S. Protecting the myocardial cell during coronary revascularization. Circulation. 2006;114(suppl I):I-339YI-343
4. Carmo-Araújo EM, Dal-Pai-Silva M, Dal-Pai V, et al. Ischaemia and reperfusion effects on skeletal muscle tissue: Morphological and histochemical studies. Int J Exp Pathol. 2007;88:147-154
5. Wang WZ, Fang XH, Stephenson LL, et al. Ischemia/reperfusion-induced necrosis and apoptosis in the cells isolated from rat skeletal muscle. J Orthop Res. 2008;26:351-356
6. Wang WZ, Baynosa RC, Zamboni WA. Update on ischemia-reperfusion injury for the plastic surgeon: 2011. Plast Reconstr Surg. 2011;128:685e.
7. Dragu A, Schnürer S, Surmann-Schmitt C, et al. Expression of HIF-1 in ischemia and reperfusion in human microsurgical free muscle tissue transfer. Plast Reconstr Surg. 2011;127:2293-2300
8. Schmidt Y, Bannasch H, Eisenhardt SU. Ischemia-reperfusion injury leads to significant tissue damage in free flap surgery [letter]. Plast Reconstr Surg. 2012;129:174eY175e.
9. Molski M, Groth A, Allison A, et al. Diannexin treatment decreases ischemiareperfusion injury at the endothelial cell level of the microvascular bed in muscle flaps. Ann Plast Surg. 2009;63:564-571
10. Mustoe T. Understanding chronic wounds: A unifying hypothesis on their pathogenesis and implications for therapy. Am J Surg. 2004;187:65SY70S.
11. Loerakker S, Manders E, Strijkers GJ, et al. The effects of deformation, ischemia, and reperfusion on the development of muscle damage during prolonged loading. J Appl Physiol. 2011;111:1168-1177
12. Kharbanda RK. Cardiac conditioning: A review of evolving strategies to reduce ischaemia and reperfusion injury. Heart. 2010;96:1179-1186
13. Halestrap AP, Pasdois P. The role of the mitochondrial permeability transition pore in heart disease. Biochim Biophys Acta. 2009;1787:1402-1415
14. Halestrap AP. Mitochondria and reperfusion injury of the heartVa holey death but not beyond salvation. J Bioenerg Biomembr. 2009;41:113-121
15. Murphy AD, McCormack MC, Bichara DA, et al. Poloxamer 188 protects against ischemia-reperfusion injury in a murine hind-limb model. Plast Reconstr Surg. 2010;125:1651-1660
16. Zhang M, Austen WG Jr, Chiu I, et al. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc Natl Acad Sci U S A. 2004;101:3886-3891
17. Chait LA, May JWJr, OBrien BM, et al. The effects of the perfusion of various solutions on the no-reflow phenomenon in experimental free flaps. Plast Reconstr Surg. 1978;61:421-430
18. Maxhimer JB, Shih HB, Isenberg JS, et al. Thrombospondin-1/CD47 blockade following ischemia-reperfusion injury is tissue protective. Plast Reconstr Surg. 2009;124:1880-1889
19. Thomas DD, Ridnour LA, Isenberg JS, et al. The chemical biology of nitric oxide: Implications in cellular signaling. Free Radic Biol Med. 2008;45:18-31
20. Li XL, Zou, XM, Gao P, et al. Role of nitric oxide in ischemia-reperfusion injury and acute rejection in rat intestinal transplantation. Transplant Proc. 2008;40:3342-3345
21. Isenberg JS, Maxhimer JB, Powers P, et al. Treatment of liver ischemiareperfusion injury by limiting thrombospondin-1/CD47 signaling. Surgery. 2008;144:752-761
22. Wang WZ, Fang XH, Stephenson LL, et al. Nitrite attenuates ischemiareperfusionYinduced microcirculatory alterations and mitochondrial dysfunction in the microvasculature of skeletal muscle. Plast Reconstr Surg. 2011;128; 279eY287e
23. Henderson PW, Singh SP, Weinstein AL, et al. Therapeutic metabolic inhibition; hydrogen sulfide significantly mitigates skeletal muscle ischemia reperfusion injury in vitro and in vivo. Plast Reconstr Surg. 2010;126:1890-1898
24. Elrod JW, Calvert JW, Duranski MR, et al. Hydrogen sulfide donor protects against acute myocardial ischemia-reperfusion injury. Circulation. 2006;114; II172
25. Henderson PW, Singh SP, Belkin DA, et al. Hydrogen sulfide protects against ischemia-reperfusion injury in an in vitro model of cutaneous tissue transplantation. J Surg Res. 2010;159:451-455
26. Jha S, Calvert JW, Duranski MR, et al. Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: Role of antioxidant and antiapoptotic signaling. Am J Physiol Heart Circ Physiol. 2008;295:H801YH806
27. Calvert JW, CoetzeeWA, Lefer DJ. Novel insights into hydrogen sulfideYmediated cytoprotection. Antioxid Redox Signal. 2010;12:1203-1217
28. Ioannou A, Dalle Lucca J, Tsokos GC. Immunopathogenesis of ischemia/ reperfusion-associated tissue damage. Clin Immunol. 2011;141:3-14
29. Friedewald JJ, Rabb H. Inflammatory cells in ischemic acute renal failure. Kidney Int. 2004;66:486-491
30. Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury, J Pathol. 2000;190:255-266
31. Scarabelli TM, Gottlieb RA. Functional and clinical repercussions of myocyte apoptosis in the multifaceted damage by ischemia/reperfusion injury: Old and new concepts after 10 years of contributions. Cell Death Differ. 2004;11(suppl 2):S144YS152
32. Eisenhardt SU, Thiele JR, Bannasch H, et al. C-reactive protein: How conformational changes influence inflammatory properties. Cell Cycle. 2009;8; 3885-3892
33. Pacher PAL, Nivorozhkin A, Szabo C. Therapeutic effects of xanthine oxidase inhibitors: Renaissance half a century after the discovery of allopurinol. Pharmacol Rev. 2006;58:87-114
34. Bolcal C, Yildirim V, Doganci S, et al. Protective effects of antioxidant medications on limb ischemia reperfusion injury. J Surg Res. 2007;139:274-279
35. Ozyurt H, Ozyurt B, Koca K, et al. Caffeic acid phenethyl ester (CAPE) protects rat skeletal muscle against ischemia-reperfusion-induced oxidative stress. Vascul Pharmacol. 2007;47:108-112
36. Kingston R, Kearns S, Kelly C, et al. Effects of systemic and regional taurine on skeletal muscle function following ischaemia-reperfusion injury. J Orthop Res. 2005;23:310-314
37. Atahan E, Ergun Y, Belge Kurutas E, et al. Ischemia-reperfusion injury in rat skeletal muscle is attenuated by zinc aspartate. J Surg Res. 2007;137:109-116
38. Erkanli K, Kayalar N, Erkanli G, et al. Melatonin protects against ischemia/ reperfusion injury in skeletal muscle. J Pineal Res. 2005;39:238-242
39. Ameln H, Gustafsson T, Sundberg CJ, et al. Physiological activation of hypoxia inducible factor-1 in human skeletal muscle. FASEB J. 2005;19:1009-1011
40. Polderman KH. Application of therapeutic hypothermia in the ICU. Intensive Care Med. 2004;30:556-575
41. Ward R, Souder N, Stahl D, et al. The role of nitric oxide synthase and heme oxygenase in the protective effect of hypothermia in ischemia-reperfusion injury. J Bone Joint Surg Am. 2009;91:2637-2645
42. Ferdinandy P, Schultz R, Baxter GF. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev. 2007;59:418-458
43. Weber C. Receptor cross-talk in remote conditioning. Nat Med. 2010;16;7
44. Pedersen C, Barnes G, Schmidt MR, et al. Ischaemia-reperfusion injury impairs tissue plasminogen activator release in man. Eur Heart J. 2011. European Heart Journal Advance Access published October 11, 2011
45. Woo KS, Armiger LC, White HD, et al. Can streptokinase produce beneficial effects additional to coronary recanalization? Quantitative microvascular analysis of critically injured reperfused myocardium. Microvasc Res. 2000;60; 8-20
46. Iwata A, Morgan-Stevenson V, Schwartz B, et al. Extracellular BCL2 proteins are danger-associated molecular patterns that reduce tissue damage in murine models of ischemia-reperfusion injury. PLoS One. 2010;5:e9103
47. Crawford RS, Albadawi H, AtkinsMD, et al. Postischemic treatment with ethyl pyruvate prevents adenosine triphosphate depletion, ameliorates inflammation, and decreases thrombosis in a murine model of hind-limb ischemia and reperfusion. J Trauma. 2011;70:103-110; discussion 110
48. Lakyová L, Toporcer T, Tomečková V, et al. Low-level laser therapy for protection against skeletal muscle damage after ischemia-reperfusion injury in rat hindlimbs. Lasers Surg Med. 2010;42:665-672
49. Crawford RS, Albadawi H, Atkins MD, et al. Postischemic poly(ADP-ribose) polymerase (PARP) inhibition reduces ischemia reperfusion injury in a hindlimb ischemia model. Surgery. 2010;148:110-118
50. Ergun Y, Oksuz H, Atli Y, et al. Ischemia-reperfusion injury in skeletal muscle; comparison of the effects of subanesthetic doses of ketamine, propofol, and etomidate. J Surg Res. 2010;159:e1Ye10
51. Wang WZ, Fang XH, Stepheson LL, et al. Acute microvascular action of vascular endothelial growth factor in skeletal muscle ischemia/reperfusion injury. Plast Reconstr Surg. 2005;115:1355-1365
52. Dillon JP, Laing AJ, Cahill RA, et al. Activated protein C attenuates acute ischaemia reperfusion injury in skeletal muscle. J Orthop Res. 2005;23:1454-1459
53. Zheng J, Wang R, Zambraski E, et al. Protective roles of adenosine A1, A2A, and A3 receptors in skeletal muscle ischemia and reperfusion injury. Am J Physiol Heart Circ Physiol. 2007;293:H3685YH3691
54. Park JW, Qi WN, Cai Y, et al. Proteasome inhibitor attenuates skeletal muscle reperfusion injury by blocking the pathway of nuclear factor-kappaB activation. Plast Reconstr Surg. 2007;120:1808-1818
55. Wang C-J, Wu R, Yang Yet al. Treatment of diabetic foot ulcers: A comparative study of extracorporeal shockwave therapy and hyperbaric oxygen therapy. Diabetes Res Clin Pract. 2011;92:187-193
56. Stekelenburg A, Oomens CWJ, Strijkers GJ, et al. Compression-induced deep tissue injury examined with magnetic resonance imaging and histology. J Appl Physiol. 2006;100:1946-1954
57. Parihar A, Parihar MS, Milner S, et al. Oxidative stress and anti-oxidative mobilization in burn injury. Burns. 2008;34:6-17
58. Traber MG, Leonard SW, Traber DL, et al. >-Tocopherol adipose tissue stores are depleted after burn injury in pediatric patients. Am J Clin Nutr. 2010;92; 1378-1384
59. Huang SS, Wei FC, Hung LM. Ischemic preconditioning attenuates postischemic leukocyte-endothelial cell interactions: Role of nitric oxide and protein kinase C. Circ J. 2006;70:1070-1075
60. Schoen M, Rotter R, Gierer P, et al. Ischemic preconditioning prevents skeletal muscle tissue injury, but not nerve lesion upon tourniquet-induced ischemia. J Trauma. 2007;63:788-797
61. Tatlidede S, McCormack MC, Eberlin KR, et al. A novel murine island skin flap for ischemic preconditioning. J Surg Res. 2009;154:112-117
62. Eberlin KR, McCormack MC, Nguyen JT, et al. Sequential limb ischemia demonstrates remote postconditioning protection of murine skeletal muscle. Plast Reconstr Surg. 2009;123(2 suppl):8SY16S.
63. McAllister SE, Ashrafpour H, Cahoon N, et al. Postconditioning for salvage of ischemic skeletal muscle from reperfusion injury: Efficacy and mechanism. Am J Physiol Regul Integr Comp Physiol. 2008;295:R681YR689
64. Tsubota H, Marui A, Esaki J, et al. Remote postconditioning may attenuate ischaemia-reperfusion injury in the murine hindlimb through adenosine receptor activation. Eur J Vasc Endovasc Surg. 2010;40:804-809